📈 Today's Market Pulse
🎯 Today's Recap
Friday wrapped up with a market that could not quite decide how it felt about itself. The S&P 500 edged up 0.29% to 7,230.12 and the Nasdaq surged 0.89% to 25,114.44, while the Dow Jones slipped 0.31% to 49,499.27. Tech lifted the indices while old-economy names felt the tariff heat.The star of the session was undeniably Apple (AAPL), which posted its biggest rally in nine months after CEO Tim Cook delivered a revenue growth outlook of 14% to 17% for the current quarter, well above what analysts expected. That kind of guidance does not come along every earnings season.
Meanwhile, factory output data from the ISM showed the purchasing managers index held steady at 52.7 in April, matching March's reading. The stability is encouraging, though rising price pressures tied to ongoing trade tensions kept a lid on the broader enthusiasm.
📊 Today's Market Movers
|
▲ Gainers
|
▼ Losers
|
🚀 What Moved Markets
Pharma had a genuinely strong Friday. The FDA approved the breast cancer drug developed jointly by Pfizer (PFE) and Arvinas (ARVN), sending ARVN shares climbing sharply. Separately, Revolution Medicines (RVMD) received FDA early-access authorization for its pancreatic cancer pill, a meaningful milestone for a disease with historically grim treatment options.On the trade front, President Trump announced plans to raise tariffs on EU automobiles and trucks to 25%, citing the EU's failure to meet trade terms. Ford (F), GM, and Stellantis (STLA) all felt pressure as investors processed what higher input costs and potential retaliatory measures could mean for Detroit's bottom line.
Intel (INTC) got a quiet but notable win when U.S. antitrust authorities cleared its investment in AI chip startup SambaNova. With Intel CEO Lip-Bu Tan chairing SambaNova, the deal had been under scrutiny, and the green light removes one regulatory overhang from the chipmaker's plate.
Sponsored Content
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move
A highly secure site in West Texas now houses an emerging potential $10 trillion technology backed by Elon Musk and Sam Altman. This breakthrough could completely replace our need for foreign oil - and send one small group of stocks soaring in the process.
🎭 Investor Mood
Investor Pulse: Cautiously Charged
Today's mood title says it best: the market is cautiously optimistic but not ready to throw a party. Tech investors are clearly feeling good after Apple's blowout guidance and the Nasdaq's outperformance, but tariff headlines have a way of keeping the celebration from getting too loud.Spirit Airlines (FLYYQ) sliding below one dollar is a jarring reminder that not every company gets to participate in the broader market's recovery. With reports that the airline's $500 million federal bailout talks have stalled, the situation looks increasingly dire for the carrier.
On the flip side, Paramount Skydance (PSKY) climbed after Morgan Stanley issued a significant upgrade tied to the Warner deal optimism, and Trump Media (DJT) named Kevin McGurn as CEO as the company navigates its unusual pivot into fusion energy. Both stories reflect how corporate transformation, for better or worse, is very much in season right now.
🔍 Tomorrow's Watchlist
- Watch AAPL closely Monday as the market continues digesting Tim Cook's 14-17% revenue growth guidance
- Monitor ARVN and PFE after Friday's FDA breast cancer drug approval for follow-through buying
- Track EU response to Trump's 25% auto tariff announcement and its effect on F, GM, and STLA
- Keep an eye on the 10-Year Treasury yield at 4.38% for any movement signaling shifting rate expectations
- Follow RVMD after its FDA early-access authorization for its pancreatic cancer pill as a key biotech catalyst
Sponsored Content
Claim your pre-IPO stake in OpenAI
Silicon Valley insider Luke Lango is stepping forward to share how you can get a pre-IPO stake in OpenAI (for under $10). It will likely be the biggest headline of 2026, and could create THOUSANDS of new millionaires. This is the best chance to achieve the biggest gains this year.
💸 The Takeaway
Apple's guidance is the kind of data point that reshapes near-term narratives. If the world's largest company by market cap is seeing 14% to 17% revenue growth, it signals that consumer demand for premium hardware remains resilient even in a tariff-heavy trade environment. That is worth sitting with over the weekend.The dual FDA approvals for Pfizer and Arvinas, plus Revolution Medicines' early-access win, underscore that the biotech and large pharma sectors are generating real clinical momentum right now. Investors watching the healthcare space should keep a close eye on how RVMD and ARVN trade in the sessions ahead as institutional money sizes up these catalysts.
Heading into next week, the 25% EU auto tariff announcement will likely draw diplomatic responses that could rattle markets again. Treasury yields stayed relatively calm with the 10-year at 4.38%, but any shift in that direction deserves attention. Stay curious, stay diversified, and enjoy the long view.
Your Phone Is Smarter Than Your Inbox
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts